Psychedelic medicine is approaching a turning point. The U.S. needs the right infrastructure to be ready

Psychedelic medicine is advancing rapidly, with rigorous clinical trials and licensed manufacturing processes. As these treatments approach wider use, the U.S. needs to prepare the necessary infrastructure.